BioPharma Dive Dec 2, 2025 Janux sinks on ‘overreaction’ to prostate cancer data; RFK Jr. replaces ACIP chair
BioPharma Dive Dec 1, 2025 Expanding access in oncology trials: The case for a paired tissue-plasma approach
BioPharma Dive Dec 1, 2025 Specialty pharmacy’s secret weapon: The unsung power of the enrollment form
BioPharma Dive Nov 26, 2025 Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3
BioPharma Dive Nov 26, 2025 Otsuka gains approval for first-of-its-kind treatment against rare kidney disease